10.1016/j.bioorg.2020.104509
The research focuses on the synthesis, biological evaluation, and QSAR studies of new thieno[2,3-d]pyrimidin-4(3H)-one derivatives as potential antimicrobial and antifungal agents. The purpose of the study was to develop new compounds that exhibit excellent activity against gram-positive and gram-negative bacteria, as well as fungal species, and to understand their structure-activity relationships. The majority of the synthesized compounds showed promising antimicrobial and antifungal activity, surpassing the potency of control compounds like streptomycin and ampicillin. Particularly, compound 22, with a m-methoxyphenyl group and an ethylenediamine side chain, demonstrated broad-spectrum antibacterial activity, while compound 15, with a m-methoxyphenyl group and a 2-(2-mercaptoethoxy)ethan-1-ol side chain, showed the best antifungal activity. Both compounds 15 and 22 showed no toxic effects in vitro on HFL-1 human embryonic primary cells and in vivo in the nematode C. elegans at their respective MIC concentrations.